Wegovy Coupon in 2026: How the Savings Card Works, Who Qualifies, and What You'll Pay

Key Takeaways

• The Wegovy savings card from Novo Nordisk reduces the monthly cost to as little as $0 if your commercial insurance covers Wegovy, or as low as $225 per month if it doesn't.
• The card is not a coupon code.
• You download it from WegovyOK.com, present it at the pharmacy with your insurance card, and the pharmacist applies it.
• The "Wegovy coupon" is shorthand for the Wegovy Savings Offer, a manufacturer copay assistance program from Novo Nordisk.
• It's not a percent-off promo code, and it's not a discount card you buy.

Direct answer (40-60 words)

The Wegovy savings card from Novo Nordisk reduces the monthly cost to as little as $0 if your commercial insurance covers Wegovy, or as low as $225 per month if it doesn't. The card is not a coupon code. You download it from WegovyOK.com, present it at the pharmacy with your insurance card, and the pharmacist applies it.

Table of contents

1. The 30-second answer
2. What the Wegovy coupon actually is
3. Who qualifies (and who's blocked)
4. Real out-of-pocket scenarios
5. Step-by-step: how to get and use the savings card
6. The $225 self-pay path (NovoCare Pharmacy)
7. Manufacturer patient assistance for low-income patients
8. Why your pharmacy says the coupon "isn't working"
9. Coupon vs compounded semaglutide cost comparison
10. When to use the coupon and when to switch paths
11. FAQ
12. Footer disclaimers

What the Wegovy coupon actually is

The "Wegovy coupon" is shorthand for the Wegovy Savings Offer, a manufacturer copay assistance program from Novo Nordisk. It's not a percent-off promo code, and it's not a discount card you buy. It's a digital or printed savings card that reduces your eligible copay at the pharmacy counter when you also have commercial insurance.

Novo Nordisk also runs a separate cash-pay path called NovoCare Pharmacy direct, which is sometimes lumped in as "the coupon" because it lowers the price for self-pay patients. The two programs work very differently.

Here's the split:

• Wegovy Savings Offer (commercial insurance): brings copays down to as little as $0 per 28-day supply if Wegovy is covered, or $225 per month if it isn't covered.
• NovoCare direct cash-pay: $499 per box of all-strength pens (sold directly through Novo Nordisk's NovoCare Pharmacy as of 2026).
• Patient Assistance Program (NovoCare PAP): free Wegovy for patients who meet income limits and lack drug coverage.

Most patients who Google "wegovy coupon" want option 1. We'll cover all three so you can pick the right path.

Who qualifies (and who's blocked)

Eligible for the Savings Offer:

• U.S. resident, age 18 or older
• Has commercial or private insurance (employer plan, marketplace plan, spouse's plan)
• Wegovy prescription for an FDA-approved indication (chronic weight management or, as of 2024, cardiovascular risk reduction in adults with obesity and established cardiovascular disease)

Blocked from the Savings Offer:

• Anyone enrolled in any government health program (Medicare, Medicaid, TRICARE, VA, IHS, CHIP)
• Anyone whose plan classifies Wegovy as not covered for any reason and the patient also lacks commercial insurance entirely
• Cash-pay patients who don't have insurance at all (these patients should look at NovoCare direct, not the savings card)
• Residents of states that legally prohibit copay assistance (rare, but a handful of state laws restrict drug-maker coupons for certain plan types)

The biggest source of confusion is the Medicare exclusion. Federal anti-kickback rules block manufacturer copay assistance for Medicare and Medicaid patients. If you're 65+ and on a Part D plan, the savings card legally cannot be applied, even if Wegovy is on your formulary.

Real out-of-pocket scenarios

The "as little as $0" headline number assumes everything goes right. Real-world costs vary a lot.

Scenario 1: Commercial insurance, Wegovy covered, deductible met. A 41-year-old with a Cigna employer plan, BMI 33, with cardiovascular risk reduction indication. Wegovy is on Tier 3 with $80 copay after deductible. Savings card brings it to $0. Monthly cost: $0.

Scenario 2: Commercial insurance, Wegovy covered, deductible not met. Same patient, but it's January and her $2,500 deductible is at $0. The pharmacy charges $1,400 negotiated rate. The savings card kicks in, capped at $225 of help per fill. She pays $1,175 out of pocket toward her deductible.

Scenario 3: Commercial insurance, Wegovy not covered. A 38-year-old with a marketplace silver plan that excludes anti-obesity meds. The savings card under the "no coverage" pathway makes Wegovy $225 per month. Monthly cost: $225.

Scenario 4: Medicare Part D. A 67-year-old on a Medicare Advantage plan. Wegovy is excluded from Medicare for weight loss but covered for cardiovascular risk reduction in qualifying patients (per the 2024 CMS expansion). Savings card cannot be used. Out-of-pocket runs $400 to $1,200 monthly depending on the plan's specialty tier.

Scenario 5: No insurance at all. A 32-year-old self-employed with no health plan. Savings card requires insurance. Path is NovoCare direct cash-pay at $499 per box, or compounded semaglutide for $179 to $279 per month.

The lesson: the savings card delivers the low advertised price only when commercial insurance covers Wegovy and your deductible has already been met.

Step-by-step: how to get and use the savings card

Step 1: Confirm your prescription is on file. The card pulls against an active prescription, so your provider's e-prescription must be at the pharmacy first.

Step 2: Visit WegovyOK.com. That's Novo Nordisk's official patient portal. Don't sign up at third-party "coupon" sites, which sometimes capture personal data and don't actually issue the card.

Step 3: Enroll. You'll provide name, email, ZIP code, and a yes/no on government insurance. The portal issues a digital card with a Group Number, BIN, PCN, and Member ID.

Step 4: Save the card. Screenshot it, save it to your phone wallet, and email a copy to yourself. Print one copy as a physical backup.

Step 5: At the pharmacy, hand the pharmacist both your insurance card and the savings card. Ask the pharmacist to run insurance first, then apply the savings card as secondary. The order matters.

Step 6: Verify the price before paying. A correctly applied savings card should drop your copay by up to $225 per fill. If your copay still looks the same, the card didn't apply. Ask the pharmacist to re-run.

Step 7: Renew when prompted. The card has annual benefit maximums, currently $1,800 per calendar year. Once you hit the maximum, the card expires and you'll need to re-enroll the next January.

The $225 self-pay path (NovoCare Pharmacy)

In late 2024, Novo Nordisk added a self-pay channel inside the savings card system. It's confusingly named, so here's what it does:

• If your commercial insurance plan denies Wegovy entirely (covers nothing), the savings card pivots to a "$225 per 28-day supply" cash-pay rate.
• This requires you to fill through specific in-network specialty pharmacies (your provider's office can help identify these), or through NovoCare Pharmacy's direct mail program.
• The $225 price is delivered as a flat cash payment, not insurance billing. It does not count toward your deductible.

This pathway is the right answer for patients with commercial insurance whose plan excludes anti-obesity medications, which is roughly 20 to 30% of commercial plans as of 2026.

A separate retail cash-pay pricing was introduced for patients with no insurance at all, sold through NovoCare Pharmacy direct. The price is $499 per box of pens (any strength), shipped to the patient's home, no insurance billing involved. It's not technically the savings card.

Manufacturer patient assistance for low-income patients

The NovoCare Patient Assistance Program (PAP) is the third Novo Nordisk pricing program, and the most under-used.

Eligibility (as of 2026):

• Household income at or below 400% of the federal poverty level (about $60,240 for an individual, $124,800 for a family of four)
• U.S. resident
• No prescription drug coverage, or coverage that doesn't include Wegovy
• Active prescription from a U.S.-licensed provider

What it provides:

• Free Wegovy for up to 12 months at a time, renewable
• Shipped directly from Novo Nordisk to the patient's address
• No copay, no deductible, no insurance involvement

How to apply:

• The provider initiates the application on NovoCare.com on the patient's behalf
• Patient signs the financial portion and provides proof of income
• Approval typically takes 5 to 10 business days

The PAP is paperwork-heavy on the provider side, which is why many practices don't routinely offer it. If your monthly cost is unaffordable and you suspect you may qualify, ask your prescriber directly to submit on your behalf.

Why your pharmacy says the coupon "isn't working"

Common reasons the savings card fails at the counter:

1. Pharmacy ran the card as primary, not secondary. The card is designed to apply after insurance. Ask the pharmacist to re-run with insurance first.
2. Government plan flag. If your insurance card looks like commercial coverage but is actually a Medicaid managed care plan or a Medicare Advantage plan, the card flags it and rejects. There's no workaround except switching to cash-pay or PAP.
3. Indication mismatch. Wegovy is FDA-approved for chronic weight management at BMI 30+ (or 27+ with comorbidity) and for cardiovascular risk reduction. If your prescription was written for an off-label indication, the card may not apply. The provider can rewrite to a covered indication if clinically appropriate.
4. Annual benefit maximum hit. The savings card has a $1,800 per calendar year cap. Once you've used $1,800 of help, the card expires for the rest of the year.
5. Expired or inactive card. Cards expire annually. Re-enroll each January.
6. Pharmacy network issue. Some independent pharmacies don't process Novo Nordisk savings cards because of payer contracting. Try a major chain (Walmart, CVS, Walgreens, Costco) if your independent pharmacy can't run it.

Calling Novo Nordisk's patient line (1-833-4WEGOVY) gets a real human within a few minutes who can troubleshoot a stuck claim.

Coupon vs compounded semaglutide cost comparison

For patients trying to decide between the Wegovy savings card path and a compounded semaglutide path, here's a side-by-side cost view.

Path	Monthly cost	Insurance required	FDA-approved	Pen vs vial
Wegovy with savings card, plan covers, deductible met	$0 to $25	Yes (commercial)	Yes	Pre-filled pen
Wegovy with savings card, plan covers, deductible NOT met	$200 to $1,400 (counts toward deductible)	Yes (commercial)	Yes	Pre-filled pen
Wegovy with savings card, plan doesn't cover	$225 flat	Yes (commercial)	Yes	Pre-filled pen
Wegovy NovoCare direct cash-pay	$499 per box	No	Yes	Pre-filled pen
Wegovy PAP (free program)	$0	No (must lack coverage)	Yes	Pre-filled pen
Compounded semaglutide (FormBlends)	$179 to $279	No	No (non-FDA approved)	Vial + U-100 syringe

The compounded path is most attractive for patients without insurance, with insurance that excludes anti-obesity meds, or with copays above $200 even with the savings card applied. The brand-name path is most attractive when the savings card brings monthly cost to $25 or less, which happens for the majority of commercially insured patients whose plan covers Wegovy.

A licensed clinician should walk through the trade-offs before either path begins. See our getting started guide for a clinical comparison.

When to use the coupon and when to switch paths

Use the savings card if:

• You have commercial insurance and Wegovy is on your formulary
• Your deductible is reasonable ($1,500 or less) or already met
• Your provider can document a covered indication
• Your monthly copay with the card applied lands under $50

Consider switching to NovoCare direct ($499 cash-pay) if:

• You have no insurance and want to stay on brand-name Wegovy
• Your insurance plan excludes Wegovy and you don't qualify for the $225 self-pay rate

Consider the PAP (free) if:

• Your household income is below 400% federal poverty level
• You're uninsured or your plan doesn't cover Wegovy
• You can have your provider's office submit on your behalf

Consider compounded semaglutide if:

• The savings card brings your copay to $200+ and that's not affordable
• You have a high-deductible plan and won't realistically meet your deductible
• You want predictable flat monthly pricing without insurance paperwork

Consider Medicare-specific pathways if:

• You're 65+ and need Wegovy for cardiovascular risk reduction (the 2024 CMS expansion may apply)
• A specialty pharmacy and your Medicare Part D plan are the right path; the savings card is not an option

FAQ

Is there a real Wegovy coupon for $25 per month? Yes, but only for patients with commercial insurance whose plan covers Wegovy. The Wegovy Savings Offer can bring the copay to as little as $0 per fill if everything aligns. The "$25" figure is sometimes quoted but the actual minimum can hit $0.

Where do I get the official Wegovy coupon? WegovyOK.com is Novo Nordisk's official enrollment site. Avoid third-party "coupon" pages, which sometimes harvest data without issuing a real card.

Does Medicare cover the Wegovy coupon? No. Federal law blocks manufacturer copay assistance for Medicare and Medicaid patients. Medicare patients pay the Part D specialty tier amount, which usually runs $400 to $1,200 monthly.

Does GoodRx work for Wegovy? GoodRx coupons sometimes show pricing for Wegovy, but the discount is small (5 to 10%). The Novo Nordisk savings card or NovoCare direct cash-pay is almost always cheaper for eligible patients.

Can I use the coupon if my insurance doesn't cover Wegovy? Yes, with the $225 per month self-pay carve-out. Your commercial plan must still be active (the card flags Medicare and Medicaid). The fill happens through specific in-network specialty pharmacies.

How long does the savings card last? The card has a $1,800 per calendar year maximum and resets each January. Re-enroll annually at WegovyOK.com.

Why is my Wegovy still expensive even with the coupon? The most likely reasons: deductible not met, plan classifies Wegovy as not-covered (savings card kicks to the $225 path), pharmacy ran the card incorrectly, or the savings card annual maximum has been exceeded.

Can I use the Wegovy coupon at any pharmacy? At most major chains (Walmart, CVS, Walgreens, Costco, Sam's Club, Kroger), yes. Some independent pharmacies don't process Novo Nordisk cards. NovoCare Pharmacy is the official direct-fill option.

What if my income is too high for the PAP but my copay is still unaffordable? The compounded semaglutide path through a state-licensed compounding pharmacy is the most common alternative. Pricing typically runs $179 to $279 per month.

Does the coupon work for Wegovy prescribed for cardiovascular risk reduction? Yes. As of the 2024 FDA expansion of Wegovy's label to include cardiovascular risk reduction, the savings card applies to that indication on commercial insurance.

Can I stack the Wegovy coupon with my HSA or FSA? You can pay your reduced copay from an HSA or FSA. The savings card itself isn't paid through HSA/FSA; it just lowers the copay you owe. The remaining out-of-pocket amount is HSA/FSA-eligible because Wegovy is a prescription medication.

Is there a Wegovy coupon for $0? For most commercially insured patients with Wegovy on their formulary and deductible met, yes, $0 per fill is achievable. The savings card pays up to $225 toward each fill, which for many copays exceeds the actual amount owed.

How is the Wegovy coupon different from the Zepbound savings card? Both are manufacturer copay assistance programs. The Wegovy card is from Novo Nordisk, the Zepbound card is from Eli Lilly. Eligibility, value, and exclusions are similar but not identical. They can't be combined; you'd use one or the other depending on which medication you're prescribed.

Author / review note

Reviewed by the FormBlends Medical Team. References include the Novo Nordisk Wegovy prescribing information (rev. 2024), the SELECT trial (Lincoff et al., NEJM, 2023) for the cardiovascular risk reduction indication, the STEP-1 trial (Wilding et al., NEJM, 2021) for chronic weight management efficacy, and CMS guidance on Medicare coverage of Wegovy for cardiovascular risk reduction (CMS memo, March 2024).

Sources

1. The Novo Nordisk Wegovy prescribing information (rev. 2024).
2. The SELECT trial (Lincoff et al., NEJM, 2023) for the cardiovascular risk reduction indication.
3. The STEP-1 trial (Wilding et al., NEJM, 2021) for chronic weight management efficacy.
4. CMS guidance on Medicare coverage of Wegovy for cardiovascular risk reduction (CMS memo, March 2024).

Footer disclaimers (all 4 verbatim)

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, and Rybelsus are registered trademarks of Novo Nordisk A/S. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. All other brand names are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.